GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro are increasingly prescribed for obesity and type 2 diabetes due to their proven effectiveness in reducing appetite, promoting weight loss, and lowering blood glucose levels.(1, 2) These medications have become extremely popular, fueled by extensive marketing to both healthcare providers and the public
Tan W, Duong MT-Q, Zuo C, Qin Y, Zhang Y, Guo Y, et al
An imbalance in reactive oxygen species (ROS) and antioxidants results in oxidative stress, which plays a central role in breast cancer initiation and progression by damaging DNA, disrupting signalling pathways, and supporting angiogenesis
doi:10.1016/j.ncl.2011.05.002
There is no Meta ad bait-and-switch, no email coupon that disappears at checkout, and no first-month promo that resets at twice the price the following month